Todd Sone

Investor at Scipher Medicine

Israel

Overview

Todd Sone is a General Partner at aMoon Fund in Israel, with a strong track record of investing in and supporting companies in the healthcare and life sciences sectors. He has successfully invested in companies like Scipher Medicine and Mobilion Systems, contributing to their growth and success. With a background in investing and serving on boards of various healthcare and biotech companies, Todd Sone has played a pivotal role in the development and advancement of innovative health technologies, making significant contributions to the industry.

Work Experience

aMoon Fund

General Partner
2021 - Current
Partnering with great HealthTech entrepreneurs.
Partner
2017 - 2021

Ultima Genomics

Investor & Board Observer
2018
Bringing the $100 genome to market.

Ultima Genomics is a developer of a low-cost sequencing platform.

Raised $600,000,000.00 from General Atlantic, Playground Global, Marius Nacht, Founders Fund, Khosla Ventures, Lightspeed Venture Partners, D1 Capital Partners, aMoon Fund and Andreessen Horowitz.

ultimagenomics.com

Scipher Medicine

Investor & Board Director
2021
Using biomarkers to reduce trial & error and help physicians make informed treatment decisions.

Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.

Raised $227,000,000.00 from Neuberger Berman, Optum Ventures, Alumni Ventures, Hitachi Ventures, Monashee Investment Management, Green D Ventures, aMoon Fund, Cowen Healthcare Investments, Khosla Ventures and Laurion Capital Management.

sciphermedicine.com